Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sigma-1 Receptors in Depression: Mechanism and Therapeutic Development
Peng Ren, Jingya Wang, Nanxi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential
Josh Allen, Shannon Dames, Claire J. Foldi, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 3, pp. 671-685
Closed Access | Times Cited: 12
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials
Dania Akbar, Taeho Greg Rhee, Felicia Ceban, et al.
CNS Drugs (2023) Vol. 37, Iss. 10, pp. 867-881
Closed Access | Times Cited: 16
Astrocyte-specific activation of sigma-1 receptors in mPFC mediates the faster onset antidepressant effect by inhibiting NF-κB-induced neuroinflammation
Jingya Wang, Peng Ren, Lin-Yu Cui, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 256-274
Closed Access | Times Cited: 6
Treatment of Depression in Huntington’s Disease: A Systematic Review
Shayan Abdollah Zadegan, Frank Ramirez, Kirthan S. Reddy, et al.
Journal of Neuropsychiatry (2024)
Closed Access | Times Cited: 5
Enhancement of neurogenesis and antidepressant-like efficacy through combined activation of Sigma-1 and 5-HT1A receptors: focus on Sigma-1-5-HT1A heteroreceptor complex
Peng Ren, Jingya Wang, Mengjie Xu, et al.
Neurochemistry International (2025), pp. 105937-105937
Closed Access
Selective activation of SIGMAR1 in anterior cingulate cortex glutamatergic neurons facilitates comorbid pain in depression in male mice
Xianlei Wang, Shulin Wu, Jiawei Zuo, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches
Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Venugopal Reddy Venna, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-15
Closed Access
The Efficacy of Fluvoxamine in Anxiety Disorders and Obsessive-Compulsive Disorder: An Overview of Systematic Reviews and Meta-Analyses
Michel Ferreira Cardia Haddad, Luiz Henrique Junqueira Dieckmann, Thiago Wendt Viola, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 353-353
Open Access
Sigma-1 receptor agonist properties that mediate the fast-onset antidepressant effect of hypidone hydrochloride (YL-0919)
Peng Ren, Jingya Wang, Honglei Chen, et al.
European Journal of Pharmacology (2023) Vol. 946, pp. 175647-175647
Closed Access | Times Cited: 12
Neurotrophic factor-based pharmacological approaches in neurological disorders
Vanessa Castelli, Margherita Alfonsetti, Michele d’Angelo
Neural Regeneration Research (2022) Vol. 18, Iss. 6, pp. 1220-1220
Open Access | Times Cited: 18
Glutamatergic Modulators for Major Depression from Theory to Clinical Use
Roger S. McIntyre, Rakesh Jain
CNS Drugs (2024) Vol. 38, Iss. 11, pp. 869-890
Open Access | Times Cited: 3
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine
Miroslav Adžić, Iva Lukić, Miloš Mitić, et al.
Life Sciences (2023) Vol. 326, pp. 121803-121803
Closed Access | Times Cited: 8
Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach
D Woodward, Jackson G. Thorp, Wọlé Akóṣílè, et al.
Psychiatry Research (2023) Vol. 326, pp. 115343-115343
Open Access | Times Cited: 5
Psychomotor symptoms, cognitive impairments and suicidal thoughts after COVID-19 infection: a case report and the possible allostatic mechanism
Ying Lin, Chen Lin, Jason Hong-Yi Chang, et al.
Annals of Geriatric Medicine and Research (2024) Vol. 28, Iss. 3, pp. 370-374
Open Access | Times Cited: 1
Current landscape of fecal microbiota transplantation in treating depression
Qi Zhang, Yajun Bi, Boyu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Role of mitochondria‐endoplasmic reticulum contacts in neurodegenerative, neurodevelopmental and neuropsychiatric conditions
Serangeli Ilaria, Diamanti Tamara, De Jaco Antonella, et al.
European Journal of Neuroscience (2024) Vol. 60, Iss. 5, pp. 5040-5068
Open Access | Times Cited: 1
SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile
Ying Xiao, Xuefeng Hu, Xing Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
A circuit from lateral hypothalamic to dorsal hippocampal dentate gyrus modulates behavioral despair in mice
Xin Huang, Shan-Shan Hu, Q Zhang, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 10
Closed Access | Times Cited: 1
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity
Laura De Luca, Lisa Lombardo, Salvatore Mirabile, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 9, pp. 1734-1742
Open Access | Times Cited: 4
Activation of σ1-Receptors by R-Ketamine May Enhance the Antidepressant Effect of S-Ketamine
Hans O. Kalkman
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2664-2664
Open Access | Times Cited: 4
The antidepressant-like effects of escitalopram in mice require salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus of the hypothalamus
Tian-Shun Shi, Wei-Yu Li, Yanmei Chen, et al.
Journal of Affective Disorders (2023) Vol. 338, pp. 228-238
Closed Access | Times Cited: 3
3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs
Raúl López‐Arnau, Jordi Camarasa, Marcel·lí Carbó, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 4
Innovative opportunities of pharmakotherapy of generalized anxiety disorder
Yevhen Denysov, G.G. Putyatin
Ukrains kyi Visnyk Psykhonevrolohii (2024), Iss. Volume 32, Issue 2 (119), 2024, pp. 32-37
Closed Access
Profiling the combination of bupropion and dextromethorphan as a treatment option for major depressive disorder
Joseph Blanco, Pamela Quimbaya, M. Mena, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 9, pp. 837-848
Closed Access
Tricyclic Antidepressant Amitriptyline Suppresses Ca2+ Responses in Rat Peritoneal Macrophages
L. S. Milenina, Z. I. Krutetskaya, В. Г. Антонов, et al.
Cell and Tissue Biology (2024) Vol. 18, Iss. 4, pp. 439-450
Closed Access
Page 1 - Next Page

Scroll to top